Listing Page

Category: Regulatory

Patent Cliff 2.0: How to Leverage the 351(k) Pathway for Biosimilars
More than $198 billion in global prescription drug sales are at risk from patent expirations between...
Read More >
Analytical Testing for Drug Development
How do you ensure that your active pharmaceutical ingredients, their starting materials and intermediates,...
Read More >
What Are the Advantages of Using QbD?
For any pharmaceutical company with a drug candidate, the objective is to provide safe and effective...
Read More >